
It’s been a week for successful trial news and for drugs being sped through the approval process. Particularly noteworthy is …

Continuous manufacturing has long been touted as the future of drug production. Pharmafile approached Novartis for more details about its successes in …

Eli Lilly has announced a strategic collaboration with KeyBioscience that sees the former company gain access to develop and commercialise …

Idorsia, the spin-off R&D company of Actelion, has been hit a blow even before it has left the ground. The …

The FDA, since the appointment of Scott Gottlieb as commissioner, has made strong noises about tackling the opioid crisis and …

If you want to understand the importance of data, look at Google and Facebook – neither company is out of …

The human papillomavirus (HPV) vaccine began to be implemented in the UK in 2008. It started by immunising girls between …

Huntington’s disease (HD) is a rare and incurable hereditary condition of the central nervous system. The condition can cause involuntary …

AbbVie posted results on upadacitinib, the latest drug in its pipeline for rheumatoid arthritis (RA) and the results have given …

Pfizer’s tafamidis has already been given approval in 40 countries across the globe but it has not currently broken into …

A recent study, conducted by the University of Cambridge, has found that DNA plays a part in determining an individual’s …

Novartis is to join forces with tech giant IBM and its Watson Health platform to tackle advanced breast cancer with …

Researchers celebrated a world-first at the American Society of Clinical Oncology conference, revealing data which showed that, in a study …

Takeda has officially launched the construction of a new €40 million expansion of its production facility in Dublin, Ireland, with …

New research data from the Mayo Clinic has suggested that as much as one in six patients suffering from atrial …

Servier, a French pharmaceutical firm, has sought to lower the fine it received from the European Commission for breaching antitrust …

The University of Oxford has joined forces with the Netherlands Cancer Institute (NKI) in an international collaboration known as Scenic …

Novartis and Bristol-Myers Squibb have announced they are to enter a clinical research partnership to investigate and assess the effectiveness …

A new tool developed by the Association of the British Pharmaceutical Industry could lead to stronger research relationships between the …

New data from late-stage trials suggests that Pfizer’s dacomitinib beat out AstraZeneca’s rival treatment Iressa (gefitinib) at halting the progression …